KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Medpace Holdings (MEDP) Receivables - Net (2016 - 2026)

Medpace Holdings filings provide 12 years of Receivables - Net readings, the most recent being $394.6 million for Q1 2026.

  • On a quarterly basis, Receivables - Net rose 32.31% to $394.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $394.6 million, a 32.31% increase, with the full-year FY2025 number at $402.1 million, up 35.63% from a year prior.
  • Receivables - Net hit $394.6 million in Q1 2026 for Medpace Holdings, down from $402.1 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $402.1 million in Q4 2025 to a low of $182.1 million in Q2 2022.
  • Median Receivables - Net over the past 5 years was $296.4 million (2024), compared with a mean of $298.1 million.
  • Biggest five-year swings in Receivables - Net: skyrocketed 71.43% in 2022 and later fell 0.66% in 2024.
  • Medpace Holdings' Receivables - Net stood at $253.4 million in 2022, then increased by 17.76% to $298.4 million in 2023, then fell by 0.66% to $296.4 million in 2024, then skyrocketed by 35.63% to $402.1 million in 2025, then fell by 1.86% to $394.6 million in 2026.
  • The last three reported values for Receivables - Net were $394.6 million (Q1 2026), $402.1 million (Q4 2025), and $373.0 million (Q3 2025) per Business Quant data.